SCHEMBL22915219

SCHEMBL22915219

Cc1cccc([C@]2(C(F)(F)F)Nc3ccccc3C(=O)O2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
NPSR1 Q6W5P4 3/20 0.50
TP53 P04637 2/20 0.46
ALDH1A1 P00352 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
CSNK1G1 Q9HCP0 1/20 0.37
POLB P06746 2/20 0.36
MAPT P10636 1/20 0.36
ROS1 P08922 1/20 0.35
CDK5 Q00535 1/20 0.35
ACVR1 Q04771 1/20 0.35
LRRK2 Q5S007 1/20 0.35
HTT P42858 1/20 0.35
PDK2 Q15119 3/20 0.35
KDM4E B2RXH2 2/20 0.35
RAD52 P43351 1/20 0.35
ATM Q13315 1/20 0.35
HCAR2 Q8TDS4 1/20 0.35
CYP1A2 P05177 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22915214 0.85 ALDH1A1 (0.50) LMNANPSR1TP53ALDH1A1TDP1
SCHEMBL22915137 0.84 TP53 (0.52) LMNANPSR1TP53ALDH1A1TDP1
SCHEMBL22915160 0.84 TP53 (0.52) LMNANPSR1TP53ALDH1A1TDP1
SCHEMBL22915142 0.84 TP53 (0.43) LMNANPSR1TP53ALDH1A1TDP1
SCHEMBL22915121 0.83 TP53 (0.52) LMNANPSR1TP53ALDH1A1TDP1
SCHEMBL22915143 0.83 TP53 (0.55) LMNANPSR1TP53ALDH1A1TDP1
SCHEMBL22915193 0.80 TP53 (0.43) LMNANPSR1TP53ALDH1A1TDP1
SCHEMBL22915211 0.78 TP53 (0.42) LMNANPSR1TP53ALDH1A1TDP1
SCHEMBL22915150 0.78 TP53 (0.43) LMNANPSR1TP53ALDH1A1TDP1
SCHEMBL22915127 0.77 TP53 (0.43) LMNANPSR1TP53ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11440892-B2 Substituted dihydrobenzoxazinones, dihydroquinolones, and methods of their use and synthesis NORTHWESTERN UNIVERSITY (US) 2022-09-13 US disclosed
US-20210024473-A1 SUBSTITUTED DIHYDROBENZOXAZINONES, DIHYDROQUINOLONES, AND METHODS OF THEIR USE AND SYNTHESIS NORTHWESTERN UNIVESITY 2021-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024473-A1 SUBSTITUTED DIHYDROBENZOXAZINONES, DIHYDROQUINOLONES, AND METHODS OF THEIR USE AND SYNTHESIS NQO1, DHPS, NQO2 LMNA 1464/4885NPSR1 3550/4885TP53 2011/4885
US-11440892-B2 Substituted dihydrobenzoxazinones, dihydroquinolones, and methods of their use and synthesis NQO1, DHPS, NQO2 LMNA 1464/4885NPSR1 3550/4885TP53 2011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.